Protein kinase C activation and the development of diabetic complications.
about
alpha2-Heremans Schmid glycoprotein, a putative inhibitor of tyrosine kinase, prevents glucose toxicity associated with cardiomyocyte dysfunctionActivation of PKC-delta and SHP-1 by hyperglycemia causes vascular cell apoptosis and diabetic retinopathyAnandamide and vanilloid TRPV1 receptorsHyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylationHow hyperglycemia promotes atherosclerosis: molecular mechanisms.The Role of AGE/RAGE Signaling in Diabetes-Mediated Vascular CalcificationIncretin-Based Therapy for Prevention of Diabetic Vascular ComplicationsHypoxia: The Force that Drives Chronic Kidney DiseaseAutophagy: A Novel Therapeutic Target for Diabetic NephropathyContractile apparatus dysfunction early in the pathophysiology of diabetic cardiomyopathyMicrovascular complications and diabetic retinopathy: recent advances and future implicationsEvidence-based hypertension treatment in patients with diabetesPathophysiology of diabetic retinopathyInflammation and oxidative stress in diabetic nephropathy: new insights on its inhibition as new therapeutic targetsMolecular mechanisms of diabetic retinopathy, general preventive strategies, and novel therapeutic targetsRedox homeostasis in pancreatic β cellsRegenerative therapies for diabetic microangiopathyAssessment of the cardiovascular and gastrointestinal autonomic complications of diabetesStore-operated calcium entry and diabetic complicationsPathogenesis of diabetic cerebral vascular disease complicationHypoxia and high glucose cause exaggerated mesangial cell growth and collagen synthesis: role of osteopontinDose- and time-dependent pharmacokinetics of midostaurin in patients with diabetes mellitusFatty acids inhibit growth-factor-induced diacylglycerol kinase alpha activation in vascular smooth-muscle cellsErythrocyte phospholipid and polyunsaturated fatty acid composition in diabetic retinopathyInvolvement of protein kinase C beta 2 in c-myc induction by high glucose in pancreatic beta-cellsProteomics and systems biology for understanding diabetic nephropathyOxidative stress and diabetic complicationsPimagedine: a novel therapy for diabetic nephropathy.Injectable hydrogel microbeads for fluorescence-based in vivo continuous glucose monitoring.Anti-angiogenic therapy of proliferative diabetic retinopathy.Regulation of the ligand binding activity of the human very low density lipoprotein receptor by protein kinase C-dependent phosphorylation.Pharmacologic therapy for diabetic retinopathy.Immunolocalization of protein kinase C isoenzymes alpha, beta I, beta II, delta, and epsilon in mouse kidney.Diabetic macular edema: classification, medical and laser therapy.Role of p90 ribosomal S6 kinase (p90RSK) in reactive oxygen species and protein kinase C beta (PKC-beta)-mediated cardiac troponin I phosphorylation.Current and future pharmacological intervention for diabetic retinopathy.[Morphologic evaluation and Ca2+ mobilization by glicose and acetylcholine in human pancreatic cells].Emerging drugs for diabetic retinopathy.Diabetic retinopathy: current management and experimental therapeutic targets.Pharmacologic therapies for diabetic retinopathy and diabetic macular edema
P2860
Q24305541-A49C8040-F5D1-4B2B-A656-82351D68A490Q24628949-94F2F223-DE5C-4905-97A9-BF7C3D8F9307Q24672354-EA30D3AE-6A7D-4802-B7EE-4FCC5219E7FBQ24682735-D566ED40-AC26-481B-85C5-F6B04D7F8273Q24795988-C088200E-F227-4C4F-9E4F-5B972E922C34Q26740003-89D1E82E-73AF-4B3A-ADC5-F92A41BD895EQ26765470-7AB36AA5-F951-4D33-97CA-2AF39BD2A957Q26768865-4A66D13D-B3B6-45E1-987A-B09B110C2388Q26771919-D3F0DFA3-9DBF-46A1-98F6-5FEB1E02D86FQ26799594-7908C81A-F990-437F-9C7F-89793302475CQ26822476-2F17D347-55ED-44E3-8C96-94E4832803E8Q26851738-17D31BAA-B3D9-4297-A8D2-6157E1199921Q26865897-3200DC15-15D0-4F76-9DD1-6E2923062EA2Q26866480-06A5610A-651D-4537-ABBB-D61203332A4FQ27014620-23660166-B43A-41BD-A09A-8F86D4772FE9Q27021930-9F009E7F-4252-46AF-B0CB-5575C5E42011Q27027852-8F78FB9E-EB7D-4FD3-8686-486FA3E57705Q28077101-37E67203-0839-4C16-B31F-6B8C5602BA12Q28085037-FB60E2DF-A2CD-41CC-9A2E-80054E66479FQ28087462-BEF237AC-B449-46BE-944E-46EB986C77B6Q28204826-0ADF7BB4-AE2A-46FA-8CAE-E9C0876CF8D7Q28281781-37CC92DD-6C3C-4D68-A213-168440A0861AQ28367258-1A45879C-AD59-4D3D-9216-ACC4557FD46FQ28542790-4E56A7BD-8064-41FF-9866-6E5FA02B14C6Q28566691-6EA34DD9-7D4F-4679-9DA8-EB77FA7164A3Q28728631-C521DB88-A14D-4073-B9E8-9185C9AEB704Q29615423-6BA900B7-F79C-4D36-BAF2-2C40C1F77CEDQ30309168-2B9BA665-96B5-44CF-932E-51675EB16F05Q30497139-01196FCC-8253-484E-81B6-B3E96171DCF1Q30666418-501DAE92-E628-4F55-AEE8-22C837F98DC4Q31442067-4A454B77-7A52-4C7B-AC0D-F1DA4510A8F7Q33194915-ECABBAB1-B9BB-44C6-BC4C-0A4B64578E38Q33200056-73A195E6-0CF4-4957-978F-8B8EA8A3726DQ33208471-B77BF67A-2830-4766-86EC-78D0CBDE3F03Q33214227-A6C1B46B-9542-4131-A9C3-60E27ABD02A4Q33216425-787C1000-4813-4666-BFFB-FDF275EA40D6Q33286587-009E6886-A161-4953-BC43-2E5376865810Q33388498-AE75F176-B4D4-4BFB-8AB4-CF24E7675DFEQ33403016-E9E95302-5CF7-4C7B-A32C-61B3985990ECQ33492340-31E28FA8-CA88-4CB3-B49B-3D7236588A0D
P2860
Protein kinase C activation and the development of diabetic complications.
description
1998 nî lūn-bûn
@nan
1998 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Protein kinase C activation and the development of diabetic complications.
@ast
Protein kinase C activation and the development of diabetic complications.
@en
Protein kinase C activation and the development of diabetic complications.
@nl
type
label
Protein kinase C activation and the development of diabetic complications.
@ast
Protein kinase C activation and the development of diabetic complications.
@en
Protein kinase C activation and the development of diabetic complications.
@nl
prefLabel
Protein kinase C activation and the development of diabetic complications.
@ast
Protein kinase C activation and the development of diabetic complications.
@en
Protein kinase C activation and the development of diabetic complications.
@nl
P1433
P1476
Protein kinase C activation and the development of diabetic complications.
@en
P304
P356
10.2337/DIABETES.47.6.859
P407
P577
1998-06-01T00:00:00Z